Belgium Calls On Europe To Take Concrete Measures On Fragile Medical Radioisotope Supply

Global medical imaging and cancer treatment supply chain heavily dependent on concentrated group of ageing reactors

Belgium Calls On Europe To Take Concrete Measures On Fragile Medical Radioisotope Supply
The core of the BR2 research reactor, which produces radioisotopes for medical imaging and cancer treatment. Courtesy SCK CEN.

Belgium’s energy minister Mathieu Bihet has called on the European Commission to improve the security of supply of crucial medical radioisotopes by strengthening the resilience of the supply chain and securing the investments needed to maintain and expand the bloc’s under-pressure and ageing production capacities.

Bihet said the initiative was vital for public health, industrial competitiveness and Europe’s “strategic autonomy”.

Belgium’s energy ministry said in a statement the initiative is supported by “numerous” member states including Luxembourg, France, Portugal, Lithuania, the Czech Republic, Slovenia, Poland, Croatia, Malta and Romania.

Want to keep reading?

Register free and get full access to NucNet for 14 days. No card required.

Republish or license this article

MORE THAN 30 YEARS OF NUCLEAR INDUSTRY REPORTING.

Subscribe for full access to every article, the archive and the SMR and AMR database.

Join NucNet